Clinical Trials Directory

Trials / Unknown

UnknownNCT04688138

Gut Microbiota and Serum Markers for Cognitive Impairment and Poor Prognosis After Ischemic Stroke

Predictive Value of Gut Microbiota and Serum Markers for Cognitive Impairment and Poor Prognosis After Ischemic Stroke: A Multiple Center Cohort Study

Status
Unknown
Phase
Study type
Observational
Enrollment
600 (estimated)
Sponsor
Nanfang Hospital, Southern Medical University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers

Summary

Post-stroke cognitive impairment(PSCI) is one of the most important factors causing disabilities after stroke. Recent study found that gut microbiota plays a key role in neurological diseases. Two recent small sample studies reported gut dysbiosis in PSCI patients. In order to further verify the relationship between PSCI and gut microbiota and the predictive value of gut microbiota and serum markers for cognitive impairment and poor prognosis after ischemic stroke. The study intended to collect stool specimens of patients with acute ischemic stroke and assess their cognitive psychological state, and to establish a prospective multi-center follow-up cohort to explore the correlation between the dynamic changes of intestinal flora in patients with stroke and PSCI and poor prognosis of stroke.

Conditions

Timeline

Start date
2020-06-01
Primary completion
2023-06-30
Completion
2023-06-30
First posted
2020-12-29
Last updated
2021-08-02

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04688138. Inclusion in this directory is not an endorsement.

Gut Microbiota and Serum Markers for Cognitive Impairment and Poor Prognosis After Ischemic Stroke (NCT04688138) · Clinical Trials Directory